Objective: The aim of the study was to evaluate the changes in eGFR in patients with
idiopathic primary aldosteronism (IHA) and with aldosterone-secreting adenoma (APA) after …

Objective Aldosterone-producing adenoma (APA) and bilateral idiopathic
hyperaldosteronism (IHA) are the most common subtypes of primary aldosteronism (PA) …

Longstanding primary aldosteronism (PA) has deleterious effects on renal function, often
masked until treatment (adrenalectomy or spironolactone) is initiated. It has been suggested …

Objective: In experimental animal models a significant association between exogenous
aldosterone excess and the progression of renal disease has been observed. However, the …

Objective: Primary aldosteronism (PA) is characterized by high risk of target organ and
cardiovascular complications Only few reports described the effect of the type of treatment …

Treatments for primary aldosteronism (PA) aim to correct or prevent the deleterious
consequences of hyperaldosteronism: hypertension, hypokalemia, and direct target organ …

Context: In primary aldosteronism (PA), glomerular hyperfiltration due to excessive
aldosterone is considered to underestimate actual renal damage. Objective: Our objectives …

Primary Hyperaldosteronism in End-Stage renal Disease: What is the benefit of surgery?
Page 1 Primary Hyperaldosteronism in End-Stage renal Disease: What is the benefit of …

Background: Diagnosis and treatment of primary aldosteronism (PA) in chronic kidney
disease (CKD) may be deferred due to limited evidence supporting safety and efficacy of …

Primary aldosteronism (PA) is one of the common forms of curable hypertension. Recent
views have suggested that PA is far from being relatively benign, as it was previously …